Skip to main content

Table 1 Demographic and baseline data of the study group

From: NS34A resistance-associated substitutions in chronic hepatitis C in Upper Egypt and regression of liver fibrosis after direct-acting antiviral therapy

Item Descriptive
1. Age “years” mean ± SD (range) 50.66 ± 9.80 (27.0–69.0)
2. Sex:
• Male 41 (69.5%)
3. BMI “kg/m2” mean ± SD (range) 27.84 ± 4.42 (19.4–39.1)
4. Diabetes mellitus:
• Yes 14(23.7%)
5. Treatment status:
• Naïve 54(91.5%)
• INF experienced 5(8.5%)
6. HCV genotype Genotype 4a (100%)
7. Baseline NS34A RASs 0 (0%)